Next Article in Journal
The Chaperone System in Salivary Glands: Hsp90 Prospects for Differential Diagnosis and Treatment of Malignant Tumors
Next Article in Special Issue
Tubular IKKβ Deletion Alleviates Acute Ischemic Kidney Injury and Facilitates Tissue Regeneration
Previous Article in Journal
Ciliary Neurotrophic Factor (CNTF) Inhibits In Vitro Cementoblast Mineralization and Induces Autophagy, in Part by STAT3/ERK Commitment
Previous Article in Special Issue
Control of Directed Cell Migration after Tubular Cell Injury by Nucleotide Signaling
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 16
10.3390/ijms23169318
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury

by
Heng-Chih Pan
1,2,3,4,†,
Yau-Hung Chen
5,†,
Wei-Ching Fang
6,
Vin-Cent Wu
7,8 and
Chiao-Yin Sun
3,*
1
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 10607, Taiwan
2
College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
3
Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 20401, Taiwan
4
Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung 20401, Taiwan
5
Department of Chemistry, Tamkang University, Tamsui, New Taipei City 25137, Taiwan
6
Department of Family Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan
7
Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei 100229, Taiwan
8
NSARF (National Taiwan University Hospital Study Group of ARF), TAIPAI, (Taiwan Primary Aldosteronism Investigators), and CAKS (Taiwan Consortium for Acute Kidney Injury and Renal Diseases), Taipei 100229, Taiwan
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2022, 23(16), 9318; https://doi.org/10.3390/ijms23169318
Submission received: 16 July 2022 / Revised: 7 August 2022 / Accepted: 16 August 2022 / Published: 18 August 2022
(This article belongs to the Special Issue New Insights into the Molecular Mechanisms of Kidney Injury and Repair)
Browse Figures
Versions Notes

Abstract

:
Background: Lysine demethylase 4C (KDM4C) is a nuclear protein that is essential for histone modification and acts as an important regulator of several transcription factors. Previous studies have shown that KDM4C may also play a role in mediating stress responses. The purpose of this study was to examine the roles of KDM4C in kidney development and acute kidney injury (AKI). Methods: The effect of KDM4C on kidney development was assessed by comparing the kidney phenotype between 96 zebrafish embryos treated with kdm4c-morpholino oligonucleotide and 96 untreated zebrafish embryos. We further examined whether KDM4C is essential for maintaining cell survival in AKI. Cultured human renal tubular cells were used for the in vitro study. Wild-type and Kdm4c knockout mice (C57BL/6NTac-Kdm4ctm1a(KOMP)Wtsi) were divided into a sham group and model group, and then subjected to ischemic reperfusion kidney injury (IRI-AKI). Blood samples and kidneys were collected at different time points (day 3, day 7, day 14, and day 28) and were processed for in vivo studies (n = 8 in each group). Results: Kdm4c knockdown significantly decreased zebrafish embryo survival and impaired kidney development. The in vitro study showed that KDM4C inhibition by JIB04 significantly increased cellular apoptosis under oxidative stress conditions. KDM4C knockdown cells had impaired autophagy function under stress conditions. The IRI-AKI mice study showed that KDM4C protein levels dynamically changed and were significantly correlated with HIF-1α levels in AKI. Kdm4c−/− mice had significantly more severe renal impairment and increased kidney fibrosis than the wild-type mice. Cytokine array results also indicated that the kidneys of Kdm4c−/− mice had increased inflammation in AKI compared with the wild-type mice. Further RNA sequence analysis revealed that KDM4C may regulate transcription factors related to mitochondrial dynamics and function. Conclusions: Our study suggests that KDM4C may play a critical role in regulating mitochondria, which is related to a protective effect on maintaining cell survival in AKI.

1. Introduction

Lysine demethylase 4C (KDM4C) is a nuclear protein that can modify histone by specifically demethylating Lys-9 and Lys-36 residues of histone H3 [1]. Investigators have demonstrated that KDM4C is critical for efficient cancer cell growth and that it is expressed in colorectal, lung, breast, prostate, and other tumor cells [2]. KDM4C acts as an important regulator of several transcription factors, including androgen and estrogen receptors [3]. In addition, KDM4C has been reported to, not only modify histones, but also regulate gene expression by directly interacting with transcription factors and changing their activities [4].
KDM4C has been shown to interact with activating transcription factor 4 (ATF4), to target serine pathway genes and activate transcription. In addition, under hypoxic stress conditions, the expression of KDM4C has been shown to be upregulated by gene transcription activation of hypoxia inducible factor-1 (HIF-1) [5]. Given that KDM4C has been shown to regulate the activities of transcription factors, including HIF-1 and ATF42, 4, and 5, KDM4C may play a role in mediating stress responses.
Ischemic reperfusion injury (IRI) is the leading cause of acute kidney injury (AKI) [6]. It results in acute tubular necrosis and apoptosis, accompanied by the rapid infiltration of polymorphonuclear leukocytes, lymphocytes, and macrophages into the interstitium. These cells are believed to be attracted to the injured kidney in response to inflammatory cytokines produced locally by cells, such as resident dendritic cell and injured tubular and endothelial cells [7]. Persistent inflammation in the kidneys is thought to contribute to the development of tubulointerstitial fibrosis with functional impairment.
Autophagy is a strictly regulated lysosomal degradation pathway under stress conditions, such as hypoxia, oxidative stress, endoplasmic reticulum stress, and deoxyribonucleic acid (DNA) damage [8,9]. It removes unnecessary or dysfunctional cell components and allows for the recycling of cellular components [10]. Autophagosome formation is tightly regulated by a series of autophagy-promoting proteins [11]. Beclin-1 and LC3 are responsible for initiation of autophagosomes, as well as the extension and closure of autophagosome double membranes, respectively [12].
The number of autophagosomes and autolysosomes can be reflected by lipidated LC3-II, which is formed by the conjugation of LC3 and phosphatidylethanolamine [13]. Autophagy is not only regulated at the post-translational level, DNA methylation and histone modifications have also been shown to be highly involved in autophagy regulation [14]. Previous studies have indicated that autophagy is crucial for the cellular homeostasis of renal tubules and is cytoprotective in response to AKI9.
Although the role of KDM4C in AKI is largely unknown, it has been reported to be involved in cell signaling, the cell cycle, and cell growth [15]. The bifunctional roles of KDM4C in histone modification and direct interactions with transcription factors also support that KDM4C plays crucial roles in regulating kidney injury [16]. However, the precise role of KDM4C in AKI has yet to be elucidated.
Numerous developmental-related genes play roles in kidney repair after AKI [17]. In the current study, we first used morpholino oligonucleo-tide (MO) to inhibit kdm4c and examine the changes in the kidney development of zebrafish. Then, a IRI-AKI mice model was further used to investigate the roles of KDM4C in the pathogenesis of AKI.

2. Results

2.1. Zebrafish Study

The kdm4c Gene Is Essential for Zebrafish Embryo Survival and Kidney Development

To assess the function of kdm4c during zebrafish kidney development, we knocked down the expression of kdm4c using kdm4c-MO, designed to bind to the region encompassing the start codon of vhl and block its translation. The results showed that kdm4c knockdown significantly decreased zebrafish embryo survival from the development stage of 8 hpf to 96 hpf (n = 96 in treated group and untreated group, respectively) (Figure 1A).
At 48 hpf, embryos derived after injecting kdm4c-MO had a more malformed kidney phenotype than the non-injected control group (Figure 1B,C). Distended pronephric tubules and swollen glomeruli are shown. Western blotting for Kdm4c in the kidneys of zebrafish embryos with or without kdm4c-MO injection are shown in Figure 1D.

2.2. Human Cell Study

2.2.1. KDM4C Inhibition Decreased Cellular Apoptosis under Oxidative Stress In Vitro

JIB04 (NSC 693627) is a selective Jumonji histone demethylase inhibitor [18]. The results demonstrated that KDM4C inhibition by JIB04 significantly increased cellular apoptosis under oxidative stress conditions (Figure 2). The percentages of dead cells significantly increased in cultured HEK293 cells treated with JIB04 during the course of oxidative stress.

2.2.2. KDM4C Depletion Impaired Autophagy In Vitro

Autophagy is a key protective mechanism for cell survival under stress conditions [19]. In this study, we used serum starvation conditions to activate autophagy in vitro [20]. The results showed that serum starvation significantly increased autophagy marker protein expressions, including cleaved LC3B, BCL1, and BCL2. In HEK293 cells with KDM4C depletion, cleaved LC3B was not observed after serum starvation.
In addition, BCL1 and BCL2 significantly decreased after 3 days of serum starvation (Figure 3A).
The immunofluorescent staining results also showed that KDM4C depletion significantly decreased LC3B puncta formation after serum starvation (Figure 3B,C). The relative levels of KDM4C in wild-type and KDM4C knockdown cells are demonstrated in Figure 3D. These findings suggest that KDM4C knockdown may impair autophagy under stress conditions.

2.3. Mice Study

2.3.1. Dynamic Changes of KDM4C Protein Levels in AKI

Mice with kidney IRI were used for this study (n = 8 in each group). The results showed that KDM4C protein levels dynamically changed in AKI, and that AKI significantly decreased kidney KDM4C expression (3 days after IRI). At 1 week after IRI, the KDM4C levels recovered, but they then decreased again, 2 to 4 weeks after IRI. HIF-1α is a master transcription factor responsible for kidney repair in AKI [21]. The Western blot results demonstrated that the dynamic changes in KDM4C levels significantly correlated with HIF-1α levels (Figure 4A). However, no significant changes in kidney H3K9M3 protein were noted during the course of injury (Figure 4A). Representative Masson trichrome staining results of kidney tissues after ischemia-reperfusion injury are shown in Figure 4B.

2.3.2. KDM4C Deletion Increased the Severity of AKI

Wild-type and Kdm4c−/− mice with ischemia-reperfusion kidney injury were used for this study (n = 8 in each group). Serum BUN and creatinine analysis revealed that the Kdm4c−/− mice had higher serum BUN and creatinine levels than the wild-type mice after acute kidney injury (Figure 5A). Representative Masson trichrome staining results of kidney tissues after ischemia-reperfusion injury are shown in Figure 5B, which demonstrated that the kidneys of the Kdm4c−/− mice had increased fibrosis compared with the kidneys of the wild-type mice.
Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) are markers of renal tubular injury [22,23], and insulin-like growth factor binding protein-2 (IGFBP-2) is also a novel marker for kidney inflammation [24]. The cytokine array results of kidney protein lysates showed that the levels of NGAL and IGFBP-2 in the kidneys of Kdm4c−/− mice were 1.5-fold higher than those of WT mice, which indicated that Kdm4c−/− mice had increased kidney inflammation after AKI compared with wild-type mice. Representative results of kidney inflammatory cytokines of the study animals were shown in the Figure 5C and Supplementary Figure S2. The relative levels of KDM4C in the kidneys of the wild-type and Kdm4c−/− mice are demonstrated in Figure 5D. These results suggested that KDM4C may play a critical role in AKI.

2.3.3. Differential Gene Expressions in the Kidneys of the Wild-Type and Kdm4c−/− Mice

Our results suggested that KDM4C is critical for kidney development and autophagy activation under stress conditions. We further investigated whether deletion of KDM4C was correlated with impaired cellular metabolic homeostasis. An RNA expression study, used to compare the gene expression levels between 10-week old wild-type and Kdm4c−/− mice under normal growth conditions (n = 8 in each group), showed that 42 genes had higher expression levels, while 46 genes had lower expression levels in the Kdm4c−/− mice than in the wild-type mice (p < 0.01) (Figure 6A). Further analysis revealed that KDM4C was involved in mitochondrial inner membrane protein complex, mitochondrial protein complex, mitochondrial electron transport chain, oxidative phosphorylation, and mitochondrial membrane phospholipid-based signal pathways, and correlated with a variety of neurodegenerative diseases and metabolic diseases (Figure 6B–D).
These findings suggested that KDM4C may be involved in mitochondrial dynamics and function. Previous studies have shown that HIF-1, LC3B II, LC3, BCL2, Beclin-1, and ATG5 are involved in the regulation of mitochondrial metabolism. Our results support that KDM4C may potentially interact with some transcription factors and play a role in the regulation of mitochondrial dynamics and function.

3. Discussion

In the present study, we demonstrated that KDM4C is essential for kidney development and plays a role in renoprotection in AKI. KDM4C deletion was related to the aggravation of AKI. Under stress conditions, KDM4C knockdown HEK293 cells had decreased expressions of LC3B, BCL1, and BCL2, suggesting that KDM4C may be involved in autophagy pathways. Moreover, we also found that KDM4C played a role in mitochondrial function.
Autophagy is essential for maintaining cell homeostasis [25]. Several protein complexes of autophagy-related proteins (Atg) are involved in the regulation of autophagy in different phases [26,27]. The Atg14L-Beclin 1-Vps34-Vps15 complex can regulate the initiation of autophagy and the maturation of autophagosomes [28]. In addition, the Atg5–Atg12/Atg16 complex and microtubule-associated protein 1 light chain 3–phosphatidyl ethanolamine (MAP1LC3/LC3–PE) can regulate the extension and completion of autophagosomes [29]. In the kidney, autophagy plays a very important role in podocyte differentiation, and it plays a crucial role in the Notch signaling pathway in the process of kidney development [11].
Our results showed that KDM4C knockdown HEK293 cells had lower expressions of LC3B I, LC3B II, BCL1, and BCL2 than wild-type cells under starvation. In addition, the inhibition of KDM4C was correlated with increased cellular apoptosis under oxidative stress conditions. These findings suggest that the deletion of KDM4C is associated with impaired autophagy in the kidneys, which may explain our finding that a lack of KDM4C gene resulted in failure of kidney development and embryo survival.
Previous studies have provided substantial evidence that autophagy is deeply involved in the regulation of inflammation and the biology of immune cells [30]. The inflammatory response is designed to control pathogen invasion and initiate tissue repair. The absence of intact autophagy function may lead to impaired cellular metabolism and inability to activate the immune system [30]. Basal autophagy is vital for the turnover of damaged organelles in renal proximal tubules in normal physiological conditions [31,32].
As demonstrated in this study, the expression levels of numerous inflammatory cytokines, as well as AKI biomarkers, were increased in the Kdm4c−/− mice, and renal damage was augmented in these mice when subjected to IRI. HIF-1α is an important transcription factor in the cell survival response to hypoxia, by regulating HIF target genes, including microRNAs [21]. Accumulating evidence has indicated that the protective effect of HIF-1α against hypoxic-ischemic injury might involve autophagy activation. Previous studies have demonstrated that HIF-1α regulates autophagy by interacting with stress response transcription factors, such as BCL1, BCL2, and mTOR [33,34,35]. Our results further indicated that the expression level of KDM4C was significantly correlated with that of HIF-1α in AKI, which suggests that KDM4C may also play a role in mediating the stress response in AKI.
Mitochondrial homeostasis is important for maintaining kidney function because of the high oxygen consumption of the kidneys [36]. Mitochondrial pathology disrupts oxidative phosphorylation and mainly affects the tissues with high rates of energy consumption, such as the proximal tubules of the kidneys [37]. Previous studies have shown that mitochondrial autophagy is activated in renal tubular cells [38,39] and that mitochondrial pathology contributes to the development of AKI and can be an early marker of AKI [40,41].
In this study, GSEA of RNA-seq data showed that KDM4C was involved in several pathways, including mitochondrial electron transport chain and oxidative phosphorylation. This suggests that KDM4C may play a role in regulating mitochondrial function. The regulation of mitochondrial gene expression has yet to be well characterized. Transcription factors can regulate the expression of mitochondrial genes indirectly and directly [42]. Although the related research is still limited, the regulatory roles of nuclear transcription factors seem to be the core processes underlying mitochondrial function [43].
Recent studies have suggested that KDM4C may play critical roles in mitochondrial function. The inhibition of KDM4C signaling has been shown to suppress prostate cancer metastasis by interfering with mitochondrial glycolytic metabolism [44]. KDM4A has also been demonstrated to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis in tumor cells [45]. Based on these findings, the regulatory roles of KDM4C on the activity of transcription factors may also be crucial for the regulation of mitochondrial dynamics and function. Our findings provide a more detailed molecular understanding of the roles of KDM4C in mitochondrial function regulation.

4. Materials and Methods

4.1. Zebrafish Study

Zebrafish Embryo Staging and Morpholino Injection

Transgenic zebrafish line Tg(wt1b:EGFP) were maintained at 28 °C with a photoperiod of 14 h light and 10 h dark, in an aquarium supplied with fresh water and aeration [46,47]. Embryos were produced using standard procedures and were staged according to standard criteria (hours post-fertilization, hpf) or by days post-fertilization (dpf) [48]. Antisense morpholino oligonucleotides (MOs), kdm4c-MO (targeting the 5′-untranslated region and the translation initiation site), were designed and obtained using Gene Tools, Philomath, OR. The MOs were dissolved in 1× Danieau solution containing 0.5% Phenol red, and 2.3 nl of MO solution at the indicated concentration was injected into 1-cell to 2-cell stages of zebrafish embryos.
To examine the phenotypic defects caused by injecting kdm4c-MO, especially defects of the glomerulus and pronephric tube, we used transgenic zebrafish line Tg(wt1b:EGFP) as the test animals18. Ninety-six zebra embryos in the treatment group received a single injection of 0.2 nM MO, and 96 were untreated. Once the embryos were collected, embryo survival, live imaging, and timely observation of renal structures were performed.
See Supplementary Figure S1A for Further Details of the Study Design.

4.2. Human Cell Study

4.2.1. Cell Culture and siRNA Plasmid Transfection

HEK293 cells were cultured under conditions suggested by ATCC. H2O2 treatment (at a concentration of 100 mM) was used to induce oxidative stress in vitro. KDM4C knockdown was carried out using KDM4C human siRNA oligo duplex (Locus ID 23081) (Origene, Rockville, MD, USA). JIB04 (Merck & Co., Inc., Kenilworth, NJ, USA) was used to inhibit KDM4C activity. For siRNA plasmid transfection, HEK293 cells were seeded in a 6-well plate (1 × 105 cells/well) and cultured for 24 h at 37 °C. The cells were then co-incubated with 10 µL Lipofectamine® 2000 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 4 µg of plasmids at 37 °C for 6 h. Subsequently, the cells were cultured with fresh medium for an additional 24 h. For the autophagy study, serum starvation was performed with serum-free culture.
See Supplementary Figure S1B,C for Further Details of the Study Design.

4.2.2. Flow Cytometry Analysis

Cultured cells were harvested, washed with cold phosphate-buffered saline (PBS), and fixed in 70% ethanol at 4 °C overnight. RNA was removed using Rnase A at 37 °C for 30 min. The cells were then stained with propidium iodide (40 µg/mL) for 30 min at room temperature and analyzed on a FACSAriaIIu_2 flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA).

4.2.3. Western Blotting Analysis

Total protein was extracted using a commercial kit, according to the manufacturer’s instructions (Protein Extraction Kit; Millipore, Burlington, MA, USA). Cell extracts (30 µg protein per lane) were mixed with a sample loading buffer and separated on 12% sodium dodecyl sulfate-polyacrylamide gel. Proteins were electrotransferred onto polyvinylidene fluoride membranes (0.2 µm; Immun-Blot; Bio-Rad, Berkeley, CA, USA). The intensity of each band was quantified using NIH Image software, and the densitometric intensity corresponding to each band was normalized against β-actin expression. The antibodies for Western blotting were KDM4C, LC3B, H3K9M3, BCL1, BCL2, HIF-1α, and actin (Cell Signaling Technology, Inc., Danvers, MA, USA).

4.2.4. Immunofluorescence Staining

Cultured cells were fixed with ice-cold acetone and incubated overnight at 4 °C with primary antibodies (anti-LC3B, Millipore, Billerica, MA, USA). The cells were then incubated with appropriate secondary immunofluorescent antibodies for 1 h at room temperature. The cell nuclei were stained with Hoechst (Molecular Probes, Eugene, OR, USA).

4.3. Mice Study

4.3.1. Ischemic Reperfusion Kidney Injury (IRI-AKI) of the Study Animals

Wild-type and Kdm4c knockout mice (C57BL/6Ntac-Kdm4ctm1a(KOMP)Wtsi) were anesthetized with an inhaled anesthesia mixture of isoflurane 2% and oxygen 1 L/min and placed on a temperature-regulated table (39 °C) to maintain body temperature. Renal ischemia was induced by clamping both renal pedicles for 45 min [49]. The sham-operated group underwent the same surgical procedure, except that clamping was not applied.
The study mice were sacrificed at the time points after ischemic reperfusion surgery illustrated (day 3, day 7, day 14, and day 28). The right kidney was harvested on ice and dissected into cortex, outer medulla, and inner medulla regions. Blood samples were collected before ischemic reperfusion surgery. After the operation, blood samples and kidneys were collected at different time points (day 3, day 7, day 14, and day 28) and were processed for different studies (n = 8 in each group).
All animal experiments were approved by the Institutional Animal Care and Use Committee of Chang Gung Memorial Hospital (IACUC number: 2008101703, 2012010903, 2021122312). Our animal center is an AAALAC certified center, and this study was performed in accordance with all the relevant guidelines and regulations.
See Supplementary Figure S1D,E for Further Details of the Study Design.

4.3.2. Histopathological Staining

Sections of paraffin-embedded specimens were stained with Masson trichrome, to assess the degree of renal fibrosis. Four random and non-overlapping sections from each kidney specimen were examined under low- and high-power fields.

4.3.3. Cytokine Array Analysis

Kidney protein lysates (100 μg) of the study animal were used for the cytokine analysis with a cytokine array (The Proteome Profiler Mouse XL Cytokine Array Kit, R&D Systems, Minneapolis, MN, USA). Excised tissue was homogenized in PBS with protease inhibitors. After homogenization, Triton X-100 was added to a final concentration of 1%. The samples were frozen at ≤−70 °C, thawed, and centrifuged at 10,000× g for 5 min to remove cellular debris. The array procedure and signal intensity calculation were then performed, according to the manufacturer’s instructions.

4.3.4. Quantification of RNA Sequencing

RNA purity and quantification were checked using a SimpliNano™—Biochrom spectrophotometer (Biochrom, Holliston, MA, USA). RNA degradation and integrity were monitored using a Qsep 100 DNA/RNA Analyzer (BiOptic Inc., New Taipei City, Taiwan). A total of 1 μg total RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using a KAPA mRNA HyperPrep Kit (KAPA Biosystems, Roche, Basel, Switzerland), following the manufacturer’s recommendations, and index codes were added to attribute sequences to each sample.
The library carrying appropriate adapter sequences at both ends was amplified using KAPA HiFi HotStart ReadyMix (KAPA Biosystems, Roche, Basel, Switzerland), along with library amplification primers. PCR products were purified using a KAPA Pure Beads system, and the library quality was assessed using the Qsep 100 DNA/RNA Analyzer (BiOptic Inc., New Taipei City, Taiwan). Library quality was assessed using Qubit@ 2.0 Fluorometer (Thermo Scientific) and Agilent Bioanalyzer 2100 systems. The library was sequenced on an Illumina NovaSeq6000 platform and 150-bp paired-end reads were generated.
The original data obtained from high-throughput sequencing (Illumina NovaSeq 6000 platform) were transformed into raw sequenced reads using the CASAVA base calling and stored in FASTQ format. FastQC and MultiQC were used to check the FASTQ files for quality. The obtained raw paired-end reads were filtered using Trimmomatic to discard low-quality reads, trim adaptor sequences, and eliminate poor-quality bases with the following parameters: LEADING:3, TRAILING:3, SLIDINGWINDOW:4:15, and MINLEN:30 [50,51]. The obtained high-quality data (clean reads) were used for subsequent analysis.
For gene expression, “trimmed mean of m-values” normalization was performed using DEGseq without biological duplicates, and “relative log expression” normalization was performed using DESeq2 with biological duplicates. Differentially expressed gene (DEG) analysis of two conditions was performed in R using DEGseq (without biological replicates) and DESeq2 [52,53,54,55]. The resulting p-values were adjusted using Benjamini and Hochberg’s approach, to control the false discovery rate (FDR). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs were conducted using clusterProfiler [56,57]. The DOSE package was used to map disease ontology (DO) terms to MeSH, ICD, NCI’s thesaurus, SNOMED, and OMIM.
Gene set enrichment analysis (GSEA) was performed with 1000 permutations, to identify enriched biological functions and activated pathways from the molecular signatures database (MsigDB) [58,59]. MsigDB is a collection of annotated gene sets for use with GSEA software, including hallmark gene sets, positional gene sets, curated gene sets, motif gene sets, computational gene sets, GO gene sets, oncogenic gene sets, and immunologic gene sets [60]. Weighted gene co-expression network analysis (WGCNA) was used to construct the co-expression network based on the correlation coefficient of expression pattern using the WGCNA package in R [61].

4.4. Statistical Analyses

The mean value and standard deviation of data from different animal groups were compared using the Mann–Whitney U test. p-values of <0.05 were considered statistically significant.

5. Conclusions

In summary, KDM4C may play a vital role in kidney development and AKI. KDM4C is essential for cell survival under stress conditions, by regulating autophagy function. In addition, KDM4C may play a transcription regulation role for mitochondrial function in the kidneys.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms23169318/s1.

Author Contributions

Research idea and study design: H.-C.P., Y.-H.C. and C.-Y.S.; data analysis/interpretation: H.-C.P., W.-C.F., Y.-H.C. and C.-Y.S.; data acquisition: W.-C.F., Y.-H.C. and C.-Y.S.; statistical analysis: H.-C.P., W.-C.F. and V.-C.W.; supervision or mentorship: V.-C.W. and C.-Y.S. Each author contributed important intellectual content during manuscript drafting or revision, accepts personal accountability for the author’s own contributions, and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Chang Gung Memorial Foundation (CMRPG-2G0361, CMRPG-2H0161, CRRPG-2B0135, CMRPG-2J0261 and CMRPG-2K0091) and the Ministry of Science and Technology, Taiwan (MOST 106-2314-B-182A-064, MOST 106-2321-B-182-002, 107-2314-B-182A-138, MOST 107-2321-B-182-004, 108-2314-B-182A-027, 108-2321-B-182-003,109-2321-B-182-001, MOST 111-2314-B-182A-074-MY3).

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available, due to ethical and privacy restrictions.

Acknowledgments

The authors thank the staff of the Community Medicine Research Center of Keelung CGMH. We also express our sincere gratitude to all participants of The Taiwan Consortium for Acute Kidney Injury and Renal Diseases (CAKs).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Whetstine, J.R.; Nottke, A.; Lan, F.; Huarte, M.; Smolikov, S.; Chen, Z.; Spooner, E.; Li, E.; Zhang, G.; Colaiacovo, M. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006, 125, 467–481. [Google Scholar] [CrossRef] [PubMed]
  2. Luo, W.; Chang, R.; Zhong, J.; Pandey, A.; Semenza, G.L. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc. Natl. Acad. Sci. USA 2012, 109, E3367–E3376. [Google Scholar] [CrossRef] [PubMed]
  3. Berry, W.L.; Janknecht, R. KDM4/JMJD2 histone demethylases: Epigenetic regulators in cancer cells. Cancer Res. 2013, 73, 2936–2942. [Google Scholar] [CrossRef] [PubMed]
  4. Zhao, E.; Ding, J.; Xia, Y.; Liu, M.; Ye, B.; Choi, J.-H.; Yan, C.; Dong, Z.; Huang, S.; Zha, Y. KDM4C and ATF4 cooperate in transcriptional control of amino acid metabolism. Cell Rep. 2016, 14, 506–519. [Google Scholar] [CrossRef] [PubMed]
  5. Pollard, P.J.; Loenarz, C.; Mole, D.R.; McDonough, M.A.; Gleadle, J.M.; Schofield, C.J.; Ratcliffe, P.J. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α. Biochem. J. 2008, 416, 387–394. [Google Scholar] [CrossRef] [PubMed]
  6. Dong, Y.; Zhang, Q.; Wen, J.; Chen, T.; He, L.; Wang, Y.; Yin, J.; Wu, R.; Xue, R.; Li, S. Ischemic duration and frequency determines AKI-to-CKD progression monitored by dynamic changes of tubular biomarkers in IRI mice. Front. Physiol. 2019, 10, 153. [Google Scholar] [CrossRef] [PubMed]
  7. Lee, S.; Huen, S.; Nishio, H.; Nishio, S.; Lee, H.K.; Choi, B.-S.; Ruhrberg, C.; Cantley, L.G. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 2011, 22, 317–326. [Google Scholar] [CrossRef]
  8. Choi, J.; Park, S.; Biering, S.B.; Selleck, E.; Liu, C.Y.; Zhang, X.; Fujita, N.; Saitoh, T.; Akira, S.; Yoshimori, T. The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for disruption by ubiquitin-like conjugation systems of autophagy. Immunity 2014, 40, 924–935. [Google Scholar] [CrossRef]
  9. Kaushal, G.P.; Shah, S.V. Autophagy in acute kidney injury. Kidney Int. 2016, 89, 779–791. [Google Scholar] [CrossRef]
  10. Mizushima, N.; Komatsu, M. Autophagy: Renovation of cells and tissues. Cell 2011, 147, 728–741. [Google Scholar] [CrossRef]
  11. Zhang, C.; Li, W.; Wen, J.; Yang, Z. Autophagy is involved in mouse kidney development and podocyte differentiation regulated by Notch signalling. J. Cell. Mol. Med. 2017, 21, 1315–1328. [Google Scholar] [CrossRef]
  12. Zeng, X.; Overmeyer, J.H.; Maltese, W.A. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J. Cell Sci. 2006, 119, 259–270. [Google Scholar] [CrossRef]
  13. Rubinsztein, D.C.; Cuervo, A.M.; Ravikumar, B.; Sarkar, S.; Korolchuk, V.I.; Kaushik, S.; Klionsky, D.J. In Search of an “Autophagomometer”; Taylor & Francis: Abingdon, UK, 2009; Volume 5, pp. 585–589. [Google Scholar]
  14. Peixoto, P.; Grandvallet, C.; Feugeas, J.-P.; Guittaut, M.; Hervouet, E. Epigenetic control of autophagy in cancer cells: A key process for cancer-related phenotypes. Cells 2019, 8, 1656. [Google Scholar] [CrossRef]
  15. Lee, D.H.; Kim, G.W.; Yoo, J.; Lee, S.W.; Jeon, Y.H.; Kim, S.Y.; Kang, H.G.; Kim, D.-H.; Chun, K.-H.; Choi, J. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc. Cell Death Dis. 2021, 12, 89. [Google Scholar] [CrossRef]
  16. Bernard, A.; Jin, M.; González-Rodríguez, P.; Füllgrabe, J.; Delorme-Axford, E.; Backues, S.K.; Joseph, B.; Klionsky, D.J. Rph1/KDM4 mediates nutrient-limitation signaling that leads to the transcriptional induction of autophagy. Curr. Biol. 2015, 25, 546–555. [Google Scholar] [CrossRef]
  17. Little, M.H.; Kairath, P. Does renal repair recapitulate kidney development? J. Am. Soc. Nephrol. 2017, 28, 34–46. [Google Scholar] [CrossRef]
  18. Wang, L.; Chang, J.; Varghese, D.; Dellinger, M.; Kumar, S.; Best, A.M.; Ruiz, J.; Bruick, R.; Peña-Llopis, S.; Xu, J. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat. Commun. 2013, 4, 2035. [Google Scholar] [CrossRef]
  19. Lee, J.; Giordano, S.; Zhang, J. Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling. Biochem. J. 2012, 441, 523–540. [Google Scholar] [CrossRef]
  20. Li, B.; Sun, C.; Sun, J.; Yang, M.-h.; Zuo, R.; Liu, C.; Lan, W.-r.; Liu, M.-h.; Huang, B.; Zhou, Y. Autophagy mediates serum starvation-induced quiescence in nucleus pulposus stem cells by the regulation of P27. Stem Cell Res. Ther. 2019, 10, 118. [Google Scholar] [CrossRef]
  21. Shu, S.; Wang, Y.; Zheng, M.; Liu, Z.; Cai, J.; Tang, C.; Dong, Z. Hypoxia and hypoxia-inducible factors in kidney injury and repair. Cells 2019, 8, 207. [Google Scholar] [CrossRef]
  22. Yang, S.-Y.; Chiou, T.T.-Y.; Shiao, C.-C.; Lin, H.Y.-H.; Chan, M.-J.; Wu, C.-H.; Sun, C.-Y.; Wang, W.-J.; Huang, Y.-T.; Wu, V.-C. Nomenclature and diagnostic criteria for acute kidney injury–2020 consensus of the Taiwan AKI-task force. J. Formos. Med. Assoc. 2021, 121, 749–765. [Google Scholar] [CrossRef] [PubMed]
  23. Pan, H.-C.; Huang, T.T.-M.; Huang, C.-T.; Sun, C.-Y.; Chen, Y.-M.; Wu, V.-C. Urinary Biomarkers Can Predict Weaning From Acute Dialysis Therapy in Critically Ill Patients. Arch. Pathol. Lab. Med. 2022. online ahead of print. [Google Scholar] [CrossRef] [PubMed]
  24. Ding, H.; Kharboutli, M.; Saxena, R.; Wu, T. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis. Clin. Exp. Immunol. 2016, 184, 11–18. [Google Scholar] [CrossRef] [PubMed]
  25. Wang, Y.; Cai, J.; Tang, C.; Dong, Z. Mitophagy in acute kidney injury and kidney repair. Cells 2020, 9, 338. [Google Scholar] [CrossRef]
  26. Galluzzi, L.; Green, D.R. Autophagy-independent functions of the autophagy machinery. Cell 2019, 177, 1682–1699. [Google Scholar] [CrossRef]
  27. Wong, P.; Puente, C.; Ganley, I.; Jiang, X. Sensing nutrient signals for autophagy activation The ULK1 complex. Autophagy 2013, 9, 124–137. [Google Scholar] [CrossRef]
  28. Yang, Z.; Klionsky, D.J. An overview of the molecular mechanism of autophagy. In Autophagy in Infection and Immunity; Levine, B., Yoshimori, T., Deretic, V., Eds.; Springer: Berlin/Heidelberg, Germany, 2009; pp. 1–32. [Google Scholar]
  29. Gómez-Sánchez, R.; Rose, J.; Guimarães, R.; Mari, M.; Papinski, D.; Rieter, E.; Geerts, W.J.; Hardenberg, R.; Kraft, C.; Ungermann, C. Atg9 establishes Atg2-dependent contact sites between the endoplasmic reticulum and phagophores. J. Cell Biol. 2018, 217, 2743–2763. [Google Scholar] [CrossRef]
  30. Arnold, J.; Murera, D.; Gros, F. Autophagy in Chronic Inflammation. In Autophagy Networks in Inflammation; Maiuri, M.C., De Stefano, D., Eds.; Springer International Publishing: Cham, Switzerland, 2016; pp. 107–133. [Google Scholar]
  31. Jiang, M.; Liu, K.; Luo, J.; Dong, Z. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am. J. Pathol. 2010, 176, 1181–1192. [Google Scholar] [CrossRef]
  32. Kimura, T.; Takabatake, Y.; Takahashi, A.; Kaimori, J.-y.; Matsui, I.; Namba, T.; Kitamura, H.; Niimura, F.; Matsusaka, T.; Soga, T. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J. Am. Soc. Nephrol. 2011, 22, 902–913. [Google Scholar] [CrossRef]
  33. Trisciuoglio, D.; Gabellini, C.; Desideri, M.; Ziparo, E.; Zupi, G.; Del Bufalo, D. Bcl-2 regulates HIF-1α protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90. PLoS ONE 2010, 5, e11772. [Google Scholar] [CrossRef]
  34. Lu, N.; Li, X.; Tan, R.; An, J.; Cai, Z.; Hu, X.; Wang, F.; Wang, H.; Lu, C.; Lu, H. HIF-1α/Beclin1-mediated autophagy is involved in neuroprotection induced by hypoxic preconditioning. J. Mol. Neurosci. 2018, 66, 238–250. [Google Scholar] [CrossRef]
  35. Yeh, Y.-H.; Hsiao, H.-F.; Yeh, Y.-C.; Chen, T.-W.; Li, T.-K. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway. J. Exp. Clin. Cancer Res. 2018, 37, 70. [Google Scholar] [CrossRef]
  36. Ralto, K.M.; Rhee, E.P.; Parikh, S.M. NAD+ homeostasis in renal health and disease. Nat. Rev. Nephrol. 2020, 16, 99–111. [Google Scholar] [CrossRef]
  37. Xiao, X.; Hu, Y.; Quirós, P.M.; Wei, Q.; López-Otín, C.; Dong, Z. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury. Am. J. Physiol.-Ren. Physiol. 2014, 306, F1318–F1326. [Google Scholar] [CrossRef]
  38. Hu, L.; Wang, H.; Huang, L.; Zhao, Y.; Wang, J. The protective roles of ROS-mediated mitophagy on 125I seeds radiation induced cell death in HCT116 cells. Oxidative Med. Cell. Longev. 2016, 2016, 9460462. [Google Scholar] [CrossRef]
  39. Yang, X.; Yan, X.; Yang, D.; Zhou, J.; Song, J.; Yang, D. Rapamycin attenuates mitochondrial injury and renal tubular cell apoptosis in experimental contrast-induced acute kidney injury in rats. Biosci. Rep. 2018, 38, BSR20180876. [Google Scholar] [CrossRef]
  40. Brooks, C.; Wei, Q.; Cho, S.-G.; Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Investig. 2009, 119, 1275–1285. [Google Scholar] [CrossRef]
  41. Funk, J.A.; Schnellmann, R.G. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am. J. Physiol.-Ren. Physiol. 2012, 302, F853–F864. [Google Scholar] [CrossRef]
  42. Scarpulla, R.C. Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 2006, 97, 673–683. [Google Scholar] [CrossRef]
  43. Leigh-Brown, S.; Enriquez, J.A.; Odom, D.T. Nuclear transcription factors in mammalian mitochondria. Genome Biol. 2010, 11, 215. [Google Scholar] [CrossRef]
  44. Lin, C.Y.; Wang, B.J.; Fu, Y.K.; Huo, C.; Wang, Y.P.; Chen, B.C.; Liu, W.Y.; Tseng, J.C.; Jiang, S.S.; Sie, Z.L. Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism. Clin. Transl. Med. 2022, 12, e764. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, L.-Y.; Hung, C.-L.; Chen, Y.-R.; Yang, J.C.; Wang, J.; Campbell, M.; Izumiya, Y.; Chen, H.-W.; Wang, W.-C.; Ann, D.K. KDM4A coactivates E2F1 to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis. Cell Rep. 2016, 16, 3016–3027. [Google Scholar] [CrossRef] [PubMed]
  46. Brukamp, K.; Jim, B.; Moeller, M.J.; Haase, V.H. Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease. Am. J. Physiol.-Ren. Physiol. 2007, 293, F1397–F1407. [Google Scholar] [CrossRef] [PubMed]
  47. Chen, Y.-H.; Lin, Y.-T.; Lee, G.-H. Novel and unexpected functions of zebrafish CCAAT box binding transcription factor (NF-Y) B subunit during cartilages development. Bone 2009, 44, 777–784. [Google Scholar] [CrossRef]
  48. Kimmel, C.B.; Ballard, W.W.; Kimmel, S.R.; Ullmann, B.; Schilling, T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995, 203, 253–310. [Google Scholar] [CrossRef]
  49. Sun, C.-Y.; Chang, S.-C.; Wu, M.-S. Uremic toxins induce kidney fibrosis by activating intrarenal renin–angiotensin–aldosterone system associated epithelial-to-mesenchymal transition. PLoS ONE 2012, 7, e34026. [Google Scholar] [CrossRef]
  50. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef]
  51. Ewels, P.; Magnusson, M.; Lundin, S.; Käller, M. MultiQC: Summarize analysis results for multiple tools and samples in a single report. Bioinformatics 2016, 32, 3047–3048. [Google Scholar] [CrossRef]
  52. Wang, L.; Feng, Z.; Wang, X.; Wang, X.; Zhang, X. DEGseq: An R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 2010, 26, 136–138. [Google Scholar] [CrossRef]
  53. Anders, S.; McCarthy, D.J.; Chen, Y.; Okoniewski, M.; Smyth, G.K.; Huber, W.; Robinson, M.D. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protoc. 2013, 8, 1765–1786. [Google Scholar] [CrossRef]
  54. Love, M.I.; Huber, W.; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15, 550. [Google Scholar] [CrossRef]
  55. Schurch, N.J.; Schofield, P.; Gierliński, M.; Cole, C.; Sherstnev, A.; Singh, V.; Wrobel, N.; Gharbi, K.; Simpson, G.G.; Owen-Hughes, T. How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use? Rna 2016, 22, 839–851. [Google Scholar] [CrossRef]
  56. Yu, G.; Wang, L.-G.; Han, Y.; He, Q.-Y. clusterProfiler: An R package for comparing biological themes among gene clusters. Omics J. Integr. Biol. 2012, 16, 284–287. [Google Scholar] [CrossRef]
  57. Kanehisa, M.; Sato, Y.; Furumichi, M.; Morishima, K.; Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019, 47, D590–D595. [Google Scholar] [CrossRef]
  58. Subramanian, A.; Tamayo, P.; Mootha, V.K.; Mukherjee, S.; Ebert, B.L.; Gillette, M.A.; Paulovich, A.; Pomeroy, S.L.; Golub, T.R.; Lander, E.S. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102, 15545–15550. [Google Scholar] [CrossRef]
  59. Yu, G.; Wang, L.-G.; Yan, G.-R.; He, Q.-Y. DOSE: An R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics 2015, 31, 608–609. [Google Scholar] [CrossRef]
  60. Liberzon, A.; Birger, C.; Thorvaldsdóttir, H.; Ghandi, M.; Mesirov, J.P.; Tamayo, P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015, 1, 417–425. [Google Scholar] [CrossRef]
  61. Langfelder, P.; Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinform. 2008, 9, 559. [Google Scholar] [CrossRef]
Ijms 23 09318 g001 550
Figure 1. Embryo survival and kidney phenotypes of zebrafish embryos (96 untreated embryos and 96 embryos treated with kdm4c-MO injection). (A). Comparison of embryo survival rate between embryos treated with a single injection of 0.2 mM kdm4c-MO and untreated embryos (n = 96 in each group). (B). Pronephric phenotypes of zebrafish embryos after kdm4c-MO injection. Each kidney photo was taken from the dorsal view and at the developmental stage of 48 hpf of bTg(wt1b:EGFP) embryos. Compared with the untreated group, after kdm4c-MO injection, the renal tubules were tortuously dilated and the glomeruli were swollen. (C). Comparison of the defect rates of morphological phenotypes (tortuously dilated renal tubules and swollen glomeruli) of zebrafish embryos between untreated group and kdm4c-MO injection group. (D). Results of Western blotting for Kdm4c with zebrafish embryo kidneys with or without kdm4c-MO injection. Abbreviation: KDM4C, Lysine demethylase 4C; MO, morpholino oligonucleotides.
Figure 1. Embryo survival and kidney phenotypes of zebrafish embryos (96 untreated embryos and 96 embryos treated with kdm4c-MO injection). (A). Comparison of embryo survival rate between embryos treated with a single injection of 0.2 mM kdm4c-MO and untreated embryos (n = 96 in each group). (B). Pronephric phenotypes of zebrafish embryos after kdm4c-MO injection. Each kidney photo was taken from the dorsal view and at the developmental stage of 48 hpf of bTg(wt1b:EGFP) embryos. Compared with the untreated group, after kdm4c-MO injection, the renal tubules were tortuously dilated and the glomeruli were swollen. (C). Comparison of the defect rates of morphological phenotypes (tortuously dilated renal tubules and swollen glomeruli) of zebrafish embryos between untreated group and kdm4c-MO injection group. (D). Results of Western blotting for Kdm4c with zebrafish embryo kidneys with or without kdm4c-MO injection. Abbreviation: KDM4C, Lysine demethylase 4C; MO, morpholino oligonucleotides.
Ijms 23 09318 g001
Ijms 23 09318 g002 550
Figure 2. KDM4C inhibition increased cell apoptosis during oxidative stress in vitro. HEK293 cells treated with the KDM4C inhibitor, JIB04 (1 μM) were used for the study. H2O2 (100 μM) treatment was used to induce oxidative stress. Cell apoptosis was analyzed by flow cytometry at the time points indicated in the figure. The percentages of dead cells at different time points after treatment are shown. Abbreviation: KDM4C, Lysine demethylase 4C.
Figure 2. KDM4C inhibition increased cell apoptosis during oxidative stress in vitro. HEK293 cells treated with the KDM4C inhibitor, JIB04 (1 μM) were used for the study. H2O2 (100 μM) treatment was used to induce oxidative stress. Cell apoptosis was analyzed by flow cytometry at the time points indicated in the figure. The percentages of dead cells at different time points after treatment are shown. Abbreviation: KDM4C, Lysine demethylase 4C.
Ijms 23 09318 g002
Ijms 23 09318 g003 550
Figure 3. KDM4C depletion impaired autophagy during serum starvation in vitro. HEK293 cells transfected with KDM4C-sh plasmid were used for the study. Cells were harvested after serum starvation at the time points indicated in the figure. (A). Results of Western blotting for autophagy markers, LC3B, BCL1, and BCL2. (B). Results of immunofluorescence staining for LC3B in control and KDM4C knockdown HEK293 cells with or without serum starvation. (C). Relative ratio of fluorescence intensities of GFP-LC3B puncta with WT as the denominator. (D). Results of Western blotting for KDM4C in control and KDM4C knockdown cells. Abbreviation: K/D, knock down; KDM4C, Lysine demethylase 4C; WT, wild-type.
Figure 3. KDM4C depletion impaired autophagy during serum starvation in vitro. HEK293 cells transfected with KDM4C-sh plasmid were used for the study. Cells were harvested after serum starvation at the time points indicated in the figure. (A). Results of Western blotting for autophagy markers, LC3B, BCL1, and BCL2. (B). Results of immunofluorescence staining for LC3B in control and KDM4C knockdown HEK293 cells with or without serum starvation. (C). Relative ratio of fluorescence intensities of GFP-LC3B puncta with WT as the denominator. (D). Results of Western blotting for KDM4C in control and KDM4C knockdown cells. Abbreviation: K/D, knock down; KDM4C, Lysine demethylase 4C; WT, wild-type.
Ijms 23 09318 g003
Ijms 23 09318 g004 550
Figure 4. Temporal changes in KDM4C and progression of kidney fibrosis during kidney injury. Wild-type mice receiving kidney ischemia-reperfusion injury (IRI) were used for this study. Kidney tissues, after IRI for the durations indicated in the figure, were harvested (n = 8 for each group). (A). Western blotting results for KDM4C, H3K9M3, and HIF-1α. The average relative ratios of KDM4C and HIF-1α along the course of injury are shown. (B). Masson trichrome staining results of kidney tissues after IRI. Mild glomerulous and tubulointerstitial fibrosis, 3 days after receiving IRI-AKI. The severity of glomerulous and tubulointerstitial fibrosis was even more pronounced 2 weeks after IRI-AKI. Abbreviation: HIF, hypoxia-inducible factor; KDM4C, Lysine demethylase 4C.
Figure 4. Temporal changes in KDM4C and progression of kidney fibrosis during kidney injury. Wild-type mice receiving kidney ischemia-reperfusion injury (IRI) were used for this study. Kidney tissues, after IRI for the durations indicated in the figure, were harvested (n = 8 for each group). (A). Western blotting results for KDM4C, H3K9M3, and HIF-1α. The average relative ratios of KDM4C and HIF-1α along the course of injury are shown. (B). Masson trichrome staining results of kidney tissues after IRI. Mild glomerulous and tubulointerstitial fibrosis, 3 days after receiving IRI-AKI. The severity of glomerulous and tubulointerstitial fibrosis was even more pronounced 2 weeks after IRI-AKI. Abbreviation: HIF, hypoxia-inducible factor; KDM4C, Lysine demethylase 4C.
Ijms 23 09318 g004
Ijms 23 09318 g005 550
Figure 5. KDM4C depletion worsened acute kidney injury. Study animals receiving kidney ischemia-reperfusion injury were used for this study. Kidney tissues and serum after ischemia-reperfusion injury for the durations indicated in the figure were harvested (n = 8 for each group). (A). Serum BUN and creatinine levels of wild-type and Kdm4c−/− mice after kidney ischemia-reperfusion injury. (B). Masson trichrome staining results of kidney tissues of wild-type and Kdm4c−/− mice after ischemia-reperfusion injury. (C). Representative results of kidney inflammatory cytokines of the study animals, 1 week after ischemia-reperfusion injury. (D). Results of Western blotting for KDM4C in the kidneys of wild-type and Kdm4c−/− mice at the age of 10 weeks. Abbreviation: BUN, blood urea nitrogen; CCL12, C-C motif ligand 12; CXCL1, C-X-C motif ligand 1; FGF, fibroblast growth factor; IGFBP-2, insulin-like growth factor binding protein-2; IL-1R, interleukin-1 receptor; KDM4C, lysine demethylase 4C. KIM-1, kidney injury molecule-1; NGAL, neutrophil gelatinase-associated lipocalin; WT, wide-type. * p < 0.05.
Figure 5. KDM4C depletion worsened acute kidney injury. Study animals receiving kidney ischemia-reperfusion injury were used for this study. Kidney tissues and serum after ischemia-reperfusion injury for the durations indicated in the figure were harvested (n = 8 for each group). (A). Serum BUN and creatinine levels of wild-type and Kdm4c−/− mice after kidney ischemia-reperfusion injury. (B). Masson trichrome staining results of kidney tissues of wild-type and Kdm4c−/− mice after ischemia-reperfusion injury. (C). Representative results of kidney inflammatory cytokines of the study animals, 1 week after ischemia-reperfusion injury. (D). Results of Western blotting for KDM4C in the kidneys of wild-type and Kdm4c−/− mice at the age of 10 weeks. Abbreviation: BUN, blood urea nitrogen; CCL12, C-C motif ligand 12; CXCL1, C-X-C motif ligand 1; FGF, fibroblast growth factor; IGFBP-2, insulin-like growth factor binding protein-2; IL-1R, interleukin-1 receptor; KDM4C, lysine demethylase 4C. KIM-1, kidney injury molecule-1; NGAL, neutrophil gelatinase-associated lipocalin; WT, wide-type. * p < 0.05.
Ijms 23 09318 g005
Ijms 23 09318 g006 550
Figure 6. Differential kidney expressions of genes between the wild-type and Kdm4c−/− mice. Kidney tissues of wild-type and Kdm4c−/− mice at the age of 10 weeks were used for this study (n = 8 in each group). (A). Volcano plot showing differential kidney gene expressions between the wild-type and Kdm4c−/− mice. The results showed that 42 genes had higher expression levels, while 46 genes had lower expression levels in the Kdm4c−/− mice than in the wild-type mice (p-value < 0.01, q-value < 0.01). (B). The KEGG pathway analysis results showed that Kdm4c deletion was also associated with a variety of neurodegenerative diseases and metabolic diseases. (C). GO enrichment analysis showed that the Kdm4c−/− mice had significantly different expressions in several pathways, including inner mitochondrial membrane protein complex and mitochondrial protein complex. (D). GSEA revealed that Kdm4c deletion was also associated with several pathways involved in mitochondrial function, including mitochondrial electron transport chain, oxidative phosphorylation, and mitochondrial membrane phospholipid-based signal pathways. Abbreviation: KDM4C, lysine demethylase 4C; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; WT, wild-type.
Figure 6. Differential kidney expressions of genes between the wild-type and Kdm4c−/− mice. Kidney tissues of wild-type and Kdm4c−/− mice at the age of 10 weeks were used for this study (n = 8 in each group). (A). Volcano plot showing differential kidney gene expressions between the wild-type and Kdm4c−/− mice. The results showed that 42 genes had higher expression levels, while 46 genes had lower expression levels in the Kdm4c−/− mice than in the wild-type mice (p-value < 0.01, q-value < 0.01). (B). The KEGG pathway analysis results showed that Kdm4c deletion was also associated with a variety of neurodegenerative diseases and metabolic diseases. (C). GO enrichment analysis showed that the Kdm4c−/− mice had significantly different expressions in several pathways, including inner mitochondrial membrane protein complex and mitochondrial protein complex. (D). GSEA revealed that Kdm4c deletion was also associated with several pathways involved in mitochondrial function, including mitochondrial electron transport chain, oxidative phosphorylation, and mitochondrial membrane phospholipid-based signal pathways. Abbreviation: KDM4C, lysine demethylase 4C; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; WT, wild-type.
Ijms 23 09318 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pan, H.-C.; Chen, Y.-H.; Fang, W.-C.; Wu, V.-C.; Sun, C.-Y. Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury. Int. J. Mol. Sci. 2022, 23, 9318. https://doi.org/10.3390/ijms23169318

AMA Style

Pan H-C, Chen Y-H, Fang W-C, Wu V-C, Sun C-Y. Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury. International Journal of Molecular Sciences. 2022; 23(16):9318. https://doi.org/10.3390/ijms23169318

Chicago/Turabian Style

Pan, Heng-Chih, Yau-Hung Chen, Wei-Ching Fang, Vin-Cent Wu, and Chiao-Yin Sun. 2022. "Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury" International Journal of Molecular Sciences 23, no. 16: 9318. https://doi.org/10.3390/ijms23169318

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop